Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Press, news & insights

Latest article

Anne-Lore Bex and Filip Van Lysebetten qualify as European Patent Attorneys

14 July 2026

De Clercq & Partners is delighted to announce that Anne-lore Bex and Filip Van Lysebetten have successfully passed the European Qualifying Examination (EQE) and are now officially qualified as European Patent Attorneys.

Passing the EQE is a significant professional achievement, requiring extensive technical expertise, legal knowledge and years of dedicated preparation. As European Patent Attorneys, Anne-Lore and Filip are qualified to represent clients before the European Patent Office (EPO), providing strategic advice and guidance throughout the European patent process.

Articles

Filter by
27 April 2026 General

New Partner Promotions!

We are very pleased to announce the promotions of Tom LiessensKris Pappaert and David Lesthaeghe to full members of the partnership at De Clercq & Partners.

Through the years, each of them has consistently demonstrated exceptional talent, leadership and dedication. Their growth reflects not only personal achievement but also the strength of our team and the bright future ahead.

20 March 2026 General

De Clercq & Partners Annual IP Seminar – 12 June 2026

We are pleased to invite you to the De Clercq & Partners Annual IP Seminar, taking place on Friday 12 June 2026 at Auberge du Pêcheur in Sint-Martens-Latem.

This full-day seminar brings together leading practitioners and experts to discuss key developments and practical challenges in intellectual property law.

16 March 2026 IP news | Patents

Update on the G1/25 Enlarged Board of Appeal referral on description amendments

January 30 marked the deadline set by the Enlarged Board of Appeal (EBoA) to file written statements regarding referral G1/25.  This deadline concerned the parties to the proceedings, third parties not taking part in the proceedings (also known as amicus curiae) and the President of the European Patent Office (EPO).  You can read the background information relating to the G1/25 referral in our article of August 5, 2025 here.